| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |